Nestmedic S.A.

WAR:NST Poland Healthcare Equipment & Supplies
Market Cap
$1.60K
zł6.67K PLN
Market Cap Rank
#47581 Global
#532 in Poland
Share Price
zł0.72
Change (1 day)
+4.35%
52-Week Range
zł0.47 - zł0.73
All Time High
zł16.70
About

Nestmedic S.A. operates in Health Care Equipment.

Nestmedic S.A. (NST) - Net Assets

Latest net assets as of June 2024: zł4.03 Million PLN

Based on the latest financial reports, Nestmedic S.A. (NST) has net assets worth zł4.03 Million PLN as of June 2024.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (zł12.50 Million) and total liabilities (zł8.47 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets zł4.03 Million
% of Total Assets 32.26%
Annual Growth Rate 18.15%
5-Year Change 78875.53%
10-Year Change N/A
Growth Volatility 8806.93

Nestmedic S.A. - Net Assets Trend (2016–2023)

This chart illustrates how Nestmedic S.A.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Nestmedic S.A. (2016–2023)

The table below shows the annual net assets of Nestmedic S.A. from 2016 to 2023.

Year Net Assets Change
2023-12-31 zł5.36 Million +61.24%
2022-12-31 zł3.33 Million +236.41%
2021-12-31 zł988.58K +162.07%
2020-12-31 zł-1.59 Million -23554.64%
2019-12-31 zł6.79K -99.74%
2018-12-31 zł2.65 Million -51.12%
2017-12-31 zł5.43 Million +225.29%
2016-12-31 zł1.67 Million --

Equity Component Analysis

This analysis shows how different components contribute to Nestmedic S.A.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 2347.4% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2023)

Component Amount Percentage
Other Components zł31.34 Million 584.51%
Total Equity zł5.36 Million 100.00%

Nestmedic S.A. Competitors by Market Cap

The table below lists competitors of Nestmedic S.A. ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Nestmedic S.A.'s equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2022 to 2023, total equity changed from 3,325,730 to 5,362,438, a change of 2,036,708 (61.2%).
  • Net loss of 6,770,135 reduced equity.
  • New share issuances of 6,399,232 increased equity.
  • Other factors increased equity by 2,407,611.

Equity Change Factors (2022 to 2023)

Factor Impact Contribution
Net Income zł-6.77 Million -126.25%
Share Issuances zł6.40 Million +119.33%
Other Changes zł2.41 Million +44.9%
Total Change zł- 61.24%

Book Value vs Market Value Analysis

This analysis compares Nestmedic S.A.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 3.31x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has increased from 1.72x to 3.31x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2018-12-31 zł0.42 zł0.72 x
2019-12-31 zł0.00 zł0.72 x
2020-12-31 zł-0.16 zł0.72 x
2021-12-31 zł0.10 zł0.72 x
2022-12-31 zł0.15 zł0.72 x
2023-12-31 zł0.22 zł0.72 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Nestmedic S.A. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -126.25%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -437.32%
  • • Asset Turnover: 0.12x
  • • Equity Multiplier: 2.36x
  • Recent ROE (-126.25%) is above the historical average (-6340.73%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2016 -63.73% -13599.23% 0.00x 1.19x zł-1.23 Million
2017 -79.10% -8411.62% 0.00x 2.14x zł-4.84 Million
2018 -154.62% -3435.11% 0.01x 3.20x zł-4.37 Million
2019 -49758.17% -712.46% 0.07x 972.60x zł-3.38 Million
2020 0.00% -615.73% 0.05x 0.00x zł-2.20 Million
2021 -395.06% -596.66% 0.06x 10.69x zł-4.00 Million
2022 -148.94% -265.30% 0.13x 4.26x zł-5.29 Million
2023 -126.25% -437.32% 0.12x 2.36x zł-7.31 Million

Industry Comparison

This section compares Nestmedic S.A.'s net assets metrics with peer companies in the Healthcare Equipment & Supplies industry.

Industry Context

  • Industry: Healthcare Equipment & Supplies
  • Average net assets among peers: $12,651,290
  • Average return on equity (ROE) among peers: -6.09%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Nestmedic S.A. (NST) zł4.03 Million -63.73% 2.10x $1.59K
INM (INM) $12.65 Million -6.09% 0.05x $281.61